- One third of type 1 diabetes patients will eventually need a new kidney
- Injecting special cells from a donor’s pancreas into the patient’s liver can help
Implanting pancreas cells from a donor into the liver of patients with type 1 diabetes can help them live longer, a study has found.
A trial led by French scientists has shown promising results for type 1 diabetics who undergo a kidney transplant.
Approximately one-third of type 1 diabetes sufferers will eventually need a new kidney due to the high blood sugar caused by the disease damaging blood vessels in the organs. Many transplant recipients will experience kidney failure again within a few years.
However, data indicates that an innovative procedure called islet transplantation can extend the time patients live without further complications following a kidney transplant.
One third of type 1 diabetes patients will eventually require a kidney transplant due to damage caused by the disease
Denial of responsibility! Vigour Times is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
Denial of responsibility! Vigour Times is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
